The Lower Austria–based company injects beneficial microorganisms directly into seeds, enabling crops- starting with soybeans - to fix nitrogen from the air and significantly reduce the need for synthetic fertilizers.
This high‑precision, fully automated process treats thousands of seeds per second, with industrial systems handling up to 1.2 tonnes of soybean seed per hour - a scale that makes biological seed treatment commercially viable for global agriculture. By protecting sensitive microbes inside the seed, the technology boosts plant resilience, lowers CO₂ emissions, and eliminates the need for on‑farm inoculation.
Ensemo is a spin-off of the Austrian Institute of Technology (AIT), building on more than 20 years of plant–microbe research. Its innovation has earned multiple recognitions, including support from the FFG and the Phoenix Founders Award 2025 for its prototype development.
With Europe as its launch market, Ensemo is preparing to scale into major soybean regions, particularly North and South America, and is already working on adapting the technology for maize and other crops in the future.
Why Singapore Should Watch Ensemo
Ensemo’s technology offers:
- Reduced upstream emissions in global supply chains
- A high-tech biological alternative that aligns with the Singapore Green Plan’s climate goals.
- Potential collaboration opportunities in microbial technologies, controlled‑environment agriculture, and regional market development.
Ensemo demonstrates how European deep tech can drive climate-smart agriculture - offering promising partnership potential for Singapore and the wider ASEAN region.
